This coformulation proved more effective than nanoparticles loaded with docetaxel only, resulting in good targeting and antitumor activity both in vitro and in vivo, including the downregulation of both P-gp and multidrug-resistance-associated protein 1 (MRP1) in lung cancer cells. The gene discussed is ABCC1; the disease is lung cancer.